Fresh ideas, bright science, next-generation therapies

ECM2026 comes at a time of real momentum for ECM research. In recent years, the field has progressed from basic biological insight to therapeutic innovation. As the first anti-fibrotic therapies reach patients, we have reason to celebrate—but also a responsibility to push further.

Fibrogenesis—linked to 40% of deaths in the Western World—remains underrepresented in therapeutic development. ECM2026 addresses this gap by convening researchers across disciplines to explore the extracellular matrix in both organ-specific and systemic disease, and to accelerate progress from mechanism to medicine.

Join us in Copenhagen, 14–17 June 2026.

Read the welcome message from Congress Chair, Prof. Morten Karsdal, below.